NASDAQDrugs and biotech company based in Chicago, IL.
These are the company news filings sent to the SEC in the last several months, newest first.
These links go to the company’s own filings on SEC EDGAR. An 8-K is often how a company announces news.
Xeris Biopharma Holdings, Inc is listed on the Nasdaq under the ticker XERS. The SEC classifies its main business as Pharmaceutical Preparations. Its fiscal year ends on December 31.
Drug and biotech companies research, test and sell medicines. Some sell approved products, others work on drugs still in testing.
Results depend on trials, approvals and patents. An investor may want to look at what is in the pipeline, when patents end, and how much cash the company has.
For education only. This is not advice to buy or sell. Figures come from the company’s SEC filings for fiscal years 2023 to 2025 and are shown as filed. Chart provided by TradingView. Always read the company’s own reports.
NASDAQDrugs and biotech company based in Chicago, IL.
These links go to the company’s own filings on SEC EDGAR. An 8-K is often how a company announces news.
Xeris Biopharma Holdings, Inc is listed on the Nasdaq under the ticker XERS. The SEC classifies its main business as Pharmaceutical Preparations. Its fiscal year ends on December 31.
Drug and biotech companies research, test and sell medicines. Some sell approved products, others work on drugs still in testing.
Results depend on trials, approvals and patents. An investor may want to look at what is in the pipeline, when patents end, and how much cash the company has.
For education only. This is not advice to buy or sell. Figures come from the company’s SEC filings for fiscal years 2023 to 2025 and are shown as filed. Chart provided by TradingView. Always read the company’s own reports.